International cancer seminars: a focus on esophageal squamous cell carcinoma.
Van Loon, K
MetadataShow full item record
Murphy, G., McCormack, V., Abedi-Ardekani, B., Arnold, M., Camargo, M., Dar, N., Dawsey, S., et al. (2017). International cancer seminars: a focus on esophageal squamous cell carcinoma.. Ann Oncol, 28 (9), 2086-2093. https://doi.org/10.1093/annonc/mdx279
The International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI) have initiated a series of cancer-focused seminars [Scelo G, Hofmann JN, Banks RE et al. International cancer seminars: a focus on kidney cancer. Ann Oncol 2016; 27(8): 1382-1385]. In this, the second seminar, IARC and NCI convened a workshop in order to examine the state of the current science on esophageal squamous cell carcinoma etiology, genetics, early detection, treatment, and palliation, was reviewed to identify the most critical open research questions. The results of these discussions were summarized by formulating a series of 'difficult questions', which should inform and prioritize future research efforts.
clinical research, early detection, epidemiology, esophageal squamous cell carcinoma (ESCC), genomics, Carcinoma, Squamous Cell, Early Detection of Cancer, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Humans, Internationality, Risk Factors
Cancer Research UK (18119)
External DOI: https://doi.org/10.1093/annonc/mdx279
This record's URL: https://www.repository.cam.ac.uk/handle/1810/284980
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org